# Arcutis Biotherapeutics, Inc.: Form 8-K, filed Feb 25, 2026

- Company: [Arcutis Biotherapeutics, Inc.](/companies/arqt.md) (CIK 1787306)
- Form: 8-K
- Filed: 2026-02-25
- Accepted by EDGAR: Feb 25, 2026, 16:04 ET
- Period: 2026-02-25
- Accession: 0001787306-26-000017
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1787306/000178730626000017/arqt-20260225.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1787306/000178730626000017/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1787306/000178730626000017/arqt-20260225.htm

Filed Feb 25, 2026.
Source: SEC EDGAR, the filing index for accession 0001787306-26-000017. Last ingested by Listed: Nov 10, 2026, 16:37 ET. No prices; not investment advice.
